Bio-Gene Technology Limited (BGT.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -2.97 Million AUD | 5.15% |
| 2023 | -3.13 Million AUD | -7.05% |
| 2022 | -2.92 Million AUD | -21.52% |
| 2021 | -2.39 Million AUD | -14.68% |
| 2020 | -2.05 Million AUD | 2.02% |
| 2019 | -2.14 Million AUD | 8.23% |
| 2018 | -3.12 Million AUD | -109.61% |
| 2017 | -1.11 Million AUD | -126.23% |
| 2016 | -493.07 Thousand AUD | -192.51% |
| 2015 | -168.58 Thousand AUD | -23.49% |
| 2014 | -136.51 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.53 Million AUD | 0.0% |
| 2024 FY | - AUD | 2.37% |
| 2024 Q4 | -924 Thousand AUD | 0.0% |
| 2023 Q2 | -2.03 Million AUD | 0.0% |
| 2023 FY | - AUD | -7.05% |
| 2023 Q4 | -1.54 Million AUD | 0.0% |
| 2022 Q2 | -1.47 Million AUD | 0.0% |
| 2022 FY | - AUD | -21.52% |
| 2022 Q4 | -1.88 Million AUD | 0.0% |
| 2021 Q4 | -1.56 Million AUD | 0.0% |
| 2021 Q1 | -468.66 Thousand AUD | 65.26% |
| 2021 FY | - AUD | -14.68% |
| 2021 Q2 | -1.35 Million AUD | -188.26% |
| 2020 Q2 | -1.53 Million AUD | 0.0% |
| 2020 Q4 | -1.34 Million AUD | -187.86% |
| 2020 Q3 | -468.66 Thousand AUD | 69.49% |
| 2020 FY | - AUD | 2.02% |
| 2019 Q3 | -502.5 Thousand AUD | 59.6% |
| 2019 FY | - AUD | 8.23% |
| 2019 Q4 | -1.32 Million AUD | -164.61% |
| 2019 Q2 | -1.24 Million AUD | 0.0% |
| 2018 Q4 | -1.26 Million AUD | -80.86% |
| 2018 FY | - AUD | -109.61% |
| 2018 Q2 | -1.22 Million AUD | 0.0% |
| 2018 Q3 | -697.76 Thousand AUD | 43.25% |
| 2017 Q4 | -720.95 Thousand AUD | 0.0% |
| 2017 FY | - AUD | -126.23% |
| 2017 Q2 | -294.2 Thousand AUD | 0.0% |
| 2016 FY | - AUD | -192.51% |
| 2015 FY | - AUD | -23.49% |
| 2014 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 128.673% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -104.233% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 91.836% |
| Biome Australia Limited | -1.57 Million AUD | -88.499% |
| Patrys Limited | -3.49 Million AUD | 14.809% |
| Orthocell Limited | -11.68 Million AUD | 74.532% |
| Imugene Limited | -147.97 Million AUD | 97.99% |
| Noxopharm Limited | -5.94 Million AUD | 49.962% |
| PYC Therapeutics Limited | -38.11 Million AUD | 92.195% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 73.672% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 58.598% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 62.281% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 70.101% |
| CSL Limited | 4.73 Billion AUD | 100.063% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 66.32% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 105.736% |
| Starpharma Holdings Limited | -12.57 Million AUD | 76.346% |
| Nanollose Limited | -1.14 Million AUD | -159.168% |
| Memphasys Limited | -3.3 Million AUD | 10.059% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -312.94% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -65.619% |
| Amplia Therapeutics Limited | -4.55 Million AUD | 34.753% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 78.627% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -5.567% |
| Race Oncology Limited | -14.2 Million AUD | 79.054% |
| Nyrada Inc. | -4.59 Million AUD | 35.273% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 112.954% |
| Dimerix Limited | -24.95 Million AUD | 88.08% |
| PharmAust Limited | -9.45 Million AUD | 68.524% |
| Immutep Limited | -42.87 Million AUD | 93.061% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 93.337% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 84.799% |
| BTC Health Limited | 1.05 Million AUD | 381.913% |
| Acrux Limited | -7.93 Million AUD | 62.489% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 101.493% |
| Biotron Limited | -5.04 Million AUD | 40.973% |
| Tissue Repair Ltd | -5.77 Million AUD | 48.485% |
| AdAlta Limited | -5.3 Million AUD | 43.897% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 93.444% |
| Hexima Limited | -995.54 Thousand AUD | -198.831% |
| AnteoTech Limited | -11.57 Million AUD | 74.289% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 95.39% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 86.068% |
| Avecho Biotechnology Limited | -3.24 Million AUD | 8.25% |
| Actinogen Medical Limited | -12.92 Million AUD | 76.976% |
| Immuron Limited | -6.19 Million AUD | 51.957% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -56.777% |